Laboratory investigations
. | Patient 1 . | . | Patient 2 . | . | . | ||
---|---|---|---|---|---|---|---|
. | 7 mo* . | 9 mo* . | 30 mo* . | 33 mo* . | Normal values . | ||
Hemoglobin level, g/dL | 8.2 | 11 | 11.7 | 6.2 | 11-13 | ||
Neutrophil count, 109/L | 2.6 | 5.0 | 2.35 | 0.85 | > 1.5 | ||
Platelet count, 109/L | 117 | 130 | 148 | 17 | 150-400 | ||
Fibrinogen level, g/L | 2.1 | 3 | NE | 2.9 | 2-4 | ||
Ferritin level, μg/L | 10 | 72 | NE | 166 | 14-197 | ||
Triglyceridemia level, mM | 1.1 | 2.6 | NE | 3.3 | 0.4-1.2 | ||
Serum sodium level, mM | 138 | 127 | 135 | 127 | 136-146 | ||
Transaminase level; ALT-AST, IU/L | 22 | 38 | 14/40 | 12/38 | 7-60 | ||
Lactate level, mM | NE | 2.5 | NE | 1.17 | 0.5-1.95 | ||
CSF investigation | |||||||
Cell count, 106/L | 25 | 75 | NE | 30 | < 10 | ||
Protein level, g/L | 1.1 | 2.6 | NE | 1.19 | < 0.3 | ||
Glucose level, mM | 0.9 | 1.5 | NE | 2.49 | 2.5-4 | ||
Lactate level, mM | NE | 3.5 | NE | 3.62 | 1.1-2.2 | ||
Immunologic investigation | |||||||
Lymphocyte count, 109/L | 8.170 | 1.640 | NR | NR | 4.000-13.500† | ||
Lymphocyte subset, % | NR | NR | 15.792 | 0.900 | 4.000-9.000‡ | ||
CD3 | NE | 59 | NE | 67 | 60-80 | ||
CD4 | NE | 40 | NE | 53 | 35-50 | ||
CD8 | NE | 15 | NE | 12 | 15-35 | ||
HLA class II (Dr+) | |||||||
CD3 | NE | 10 | NE | 31 | ≤ 15 | ||
CD4 | NE | 8 | NE | 26 | ≤ 15 | ||
CD8 | NE | 20 | NE | 51 | ≤ 15 |
. | Patient 1 . | . | Patient 2 . | . | . | ||
---|---|---|---|---|---|---|---|
. | 7 mo* . | 9 mo* . | 30 mo* . | 33 mo* . | Normal values . | ||
Hemoglobin level, g/dL | 8.2 | 11 | 11.7 | 6.2 | 11-13 | ||
Neutrophil count, 109/L | 2.6 | 5.0 | 2.35 | 0.85 | > 1.5 | ||
Platelet count, 109/L | 117 | 130 | 148 | 17 | 150-400 | ||
Fibrinogen level, g/L | 2.1 | 3 | NE | 2.9 | 2-4 | ||
Ferritin level, μg/L | 10 | 72 | NE | 166 | 14-197 | ||
Triglyceridemia level, mM | 1.1 | 2.6 | NE | 3.3 | 0.4-1.2 | ||
Serum sodium level, mM | 138 | 127 | 135 | 127 | 136-146 | ||
Transaminase level; ALT-AST, IU/L | 22 | 38 | 14/40 | 12/38 | 7-60 | ||
Lactate level, mM | NE | 2.5 | NE | 1.17 | 0.5-1.95 | ||
CSF investigation | |||||||
Cell count, 106/L | 25 | 75 | NE | 30 | < 10 | ||
Protein level, g/L | 1.1 | 2.6 | NE | 1.19 | < 0.3 | ||
Glucose level, mM | 0.9 | 1.5 | NE | 2.49 | 2.5-4 | ||
Lactate level, mM | NE | 3.5 | NE | 3.62 | 1.1-2.2 | ||
Immunologic investigation | |||||||
Lymphocyte count, 109/L | 8.170 | 1.640 | NR | NR | 4.000-13.500† | ||
Lymphocyte subset, % | NR | NR | 15.792 | 0.900 | 4.000-9.000‡ | ||
CD3 | NE | 59 | NE | 67 | 60-80 | ||
CD4 | NE | 40 | NE | 53 | 35-50 | ||
CD8 | NE | 15 | NE | 12 | 15-35 | ||
HLA class II (Dr+) | |||||||
CD3 | NE | 10 | NE | 31 | ≤ 15 | ||
CD4 | NE | 8 | NE | 26 | ≤ 15 | ||
CD8 | NE | 20 | NE | 51 | ≤ 15 |